MarketCapExport financials
eHealth (EHTH)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
eHealth Income Statement 2025-2008 | EHTH
Brief overview of income trends at eHealth
The conclusions below are based on five years of reported results. According to figures from eHealth, revenue changed from $583 million to $554 million over five years. The five-year change reached −4.9%, while CAGR stood at −1%. The business did not achieve meaningful top-line expansion.
Net profit was $45.5 million at the start and $40 million at the end. The decline reduces the quality of the financial trajectory.
The market value of the business moved from 1.8 billion dollars to 47.3 million dollars, or −97.4%. Market value lagged the financial performance.
Conclusion
Signs of deterioration dominate the five-year picture. The overall view is constrained by weak sales momentum, declining net profitability and lower investor confidence. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement eHealth
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
47.3 M | 262 M | 184 M | 220 M | 683 M | 1.84 B | 2.61 B | 1.14 B | 331 M | 221 M | 189 M | 188 M | 1.02 B | 482 M | 333 M | 292 M | 405 M | - |
Shares |
30.5 M | 29.3 M | 28 M | 27.4 M | 26.8 M | 26 M | 23.1 M | 19.3 M | 18.5 M | 18.3 M | 18 M | 18.4 M | 19.1 M | 19.9 M | 20.9 M | 23.1 M | 24.3 M | - |
Historical Prices |
1.55 | 8.93 | 6.56 | 8.03 | 25.5 | 70.6 | 96.1 | 38.4 | 17.4 | 10.7 | 9.98 | 24.9 | 46.5 | 27.5 | 14.7 | 12.6 | 16.7 | 24 |
Net Income |
40 M | 10.1 M | -28.2 M | -88.7 M | -104 M | 45.4 M | 66.9 M | 241 K | -25.4 M | -4.88 M | -4.76 M | -16.2 M | 1.72 M | 7.08 M | 6.72 M | 17.5 M | 15.3 M | - |
Revenue |
554 M | 532 M | 453 M | 405 M | 538 M | 583 M | 506 M | 251 M | 172 M | 187 M | 190 M | 180 M | 179 M | 155 M | 152 M | 160 M | 135 M | - |
Cost of Revenue |
1.33 M | 1.79 M | 1.77 M | 1.65 M | 1.99 M | 4.08 M | 2.74 M | 1.23 M | 582 K | 862 K | 1.95 M | 4.49 M | 5.46 M | 4.78 M | 8.34 M | 5.5 M | 4.58 M | - |
Gross Profit |
241 M | 208 M | 159 M | - | - | - | 503 M | 250 M | 170 M | 184 M | 185 M | 175 M | 174 M | 151 M | 143 M | - | - | - |
Operating Income |
66.5 M | 23.6 M | -29.1 M | -103 M | -126 M | 53.3 M | 81.4 M | 2.55 M | -9.45 M | 2.82 M | 10.4 M | -6.76 M | 3.73 M | 13.4 M | 13.2 M | 32.6 M | 25.8 M | - |
Interest Expense |
3 M | 6.9 M | 9.45 M | 7.63 M | 845 K | 666 K | 2.09 M | 755 K | 1.18 M | 1.15 M | 1.28 M | -98 K | -92 K | 23 K | -53 K | 9 K | - | - |
EBITDA |
68.4 M | 25.6 M | -26.5 M | -81.6 M | -107 M | 64.8 M | 108 M | 18.9 M | -27.8 M | -5.11 M | 43 K | -5.23 M | 5.15 M | 15 M | 15.3 M | 34.8 M | 28.1 M | - |
Operating Expenses |
- | - | - | - | - | - | 398 M | 233 M | 199 M | 190 M | 186 M | 182 M | 170 M | 137 M | 130 M | - | - | - |
General and Administrative Expenses |
89.6 M | 89.8 M | 99.4 M | 71.8 M | 75.7 M | 76.5 M | 246 M | 148 M | 132 M | 117 M | 110 M | 111 M | 96.9 M | 77.9 M | 49.5 M | 24.1 M | 20 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement eHealth
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
31.8 M | 31.1 M | 30.6 M | 30.4 M | 30 M | 29.5 M | 29.2 M | 28.9 M | 28.1 M | 27.8 M | 27.6 M | - | 27.3 M | 27.3 M | 27.3 M | 26.7 M | 26.8 M | 26.7 M | 26.6 M | 25.9 M | 26.5 M | 26.4 M | 24.7 M | 23.1 M | 23.5 M | 23.1 M | 21.8 M | 19.4 M | 19.2 M | 19.1 M | 18.9 M | 18.6 M | 18.6 M | 18.5 M | 18.4 M | 18.4 M | 18.3 M | 18.3 M | 18.2 M | 18.1 M | 18.1 M | 18 M | 17.8 M | 17.8 M | 17.8 M | 19 M | 18.8 M | 18.8 M | 18.4 M | 18.9 M | 20.6 M | 20.4 M | 20 M | 19.6 M | 19.5 M | 19.9 M | 21.1 M | 21.4 M | 21.4 M |
Net Income |
-23.6 M | -4.71 M | -31.7 M | -17.4 M | 1.95 M | -42.5 M | -28 M | -17 M | -37 M | -23.5 M | -19.9 M | - | -39.1 M | -37.5 M | -32.7 M | - | -53 M | -18.4 M | -800 K | - | -14.5 M | -3.37 M | 3.45 M | 88.8 M | -11 M | -5.75 M | -5.16 M | 26.1 M | -8.97 M | -12 M | -4.84 M | 28 M | -2.18 M | -1.51 M | 1.08 M | -3.84 M | 3.45 M | 1.5 M | -795 K | -12.1 M | 3.64 M | 5.75 M | -2.08 M | -19.2 M | 1.52 M | 3.02 M | -1.55 M | -1.96 M | 174 K | 1.15 M | 2.36 M | 2.45 M | 205 K | 2.3 M | 2.12 M | 2.26 M | -249 K | 2.73 M | 1.98 M |
Revenue |
33.6 M | 88 M | 53.9 M | 60.8 M | 113 M | 58.4 M | 65.9 M | 93 M | 64.7 M | 66.8 M | 73.7 M | - | 53.4 M | 50.4 M | 105 M | - | 63.9 M | 96.6 M | 134 M | - | 94.3 M | 88.8 M | 106 M | 302 M | 69.9 M | 65.8 M | 68.8 M | 135 M | 40.8 M | 32.7 M | 43.1 M | 83.1 M | 31.5 M | 34.6 M | 41.6 M | 77.4 M | 32.1 M | 37.3 M | 73.8 M | 50.1 M | 38.2 M | 39.9 M | 61.3 M | 45 M | 41.2 M | 42.6 M | 50.9 M | 54.2 M | 42 M | 39.8 M | 43.2 M | 45.3 M | 37.6 M | 35.5 M | 37.1 M | 43.1 M | 34.8 M | 36.2 M | 37.6 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | 215 K | - | 494 K | 423 K | -127 K | - | -25 K | 246 K | 996 K | - | 482 K | 540 K | 1.14 M | - | 410 K | 449 K | -77 K | - | 170 K | 151 K | 152 K | - | -9 K | 56 K | 181 K | - | 30 K | 533 K | 2.18 M | - | 443 K | 670 K | 2.41 M | - | 745 K | 892 K | 2.11 M | - | 806 K | 984 K | 2.65 M | - | 1.1 M | 764 K | 1.68 M | - | 1.78 M | 2.56 M | 2.65 M |
Gross Profit |
5.12 M | 36.7 M | -180 K | 18.9 M | 41.7 M | - | 18.9 M | 29.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-27.5 M | -2.88 M | -41.5 M | -23 M | 4.8 M | -43.2 M | -28 M | -17.9 M | -39.4 M | -26.2 M | -22.9 M | - | -48.3 M | -45.5 M | -39.7 M | - | -66 M | -25.3 M | -642 K | - | -20.8 M | -6.25 M | 1.03 M | 123 M | -20.2 M | -12.3 M | -9.18 M | 41.6 M | -15.5 M | -16.9 M | -6.72 M | 20.8 M | -15.7 M | -10.5 M | -4.11 M | 16.7 M | -10.1 M | -6.99 M | 3.15 M | -12.4 M | 2.92 M | 5.83 M | -2.01 M | -13.8 M | 3.77 M | 6.35 M | -3.11 M | -2.64 M | 403 K | 2.03 M | 3.94 M | 4.31 M | 1.08 M | 4.14 M | 3.91 M | 4.38 M | 43 K | 4.85 M | 3.97 M |
Interest Expense |
832 K | 840 K | 978 K | 1.34 M | 1.58 M | 1.7 M | 2.34 M | 2.39 M | 2.68 M | 2.83 M | 2.58 M | - | -647 K | -1.17 M | -1.02 M | - | 189 K | 172 K | 150 K | - | -101 K | 452 K | 373 K | - | 568 K | 699 K | 557 K | - | 296 K | 296 K | 184 K | - | 300 K | 298 K | 277 K | - | 7 K | -21 K | -11 K | - | -27 K | -9 K | -14 K | - | -13 K | -29 K | -39 K | - | -22 K | -21 K | -25 K | - | 4 K | 16 K | 21 K | - | -21 K | -21 K | - |
EBITDA |
-26.5 M | -2.39 M | -40.1 M | -22.1 M | 5.27 M | -39.4 M | -23.7 M | -17.4 M | -34.7 M | -21 M | -17.6 M | - | -42.7 M | -40.1 M | -34.9 M | - | -61.1 M | -21.3 M | 3.3 M | - | -17.9 M | -3.66 M | 3.36 M | 123 M | -19.5 M | -11.6 M | -8.53 M | 41.6 M | -14.8 M | -16.3 M | -6.1 M | 20.8 M | -15 M | -9.72 M | -3.35 M | 16.7 M | -9.26 M | -6.06 M | 4.15 M | -12.4 M | 6.05 M | 7.94 M | -954 K | -13.8 M | 6.88 M | 8.41 M | -2.11 M | -2.64 M | 2.69 M | 3.42 M | 4.58 M | 4.31 M | 2.82 M | 5.25 M | 4.48 M | 4.38 M | 1.84 M | 6.12 M | 4.64 M |
General and Administrative Expenses |
15.6 M | 15.5 M | 21.9 M | 21.6 M | 17.3 M | 20.3 M | 22.4 M | 19.6 M | 22.9 M | 25 M | 24.3 M | - | 17.3 M | 17.2 M | 20 M | - | 16.6 M | 18.1 M | 23.1 M | - | 19.9 M | 20.7 M | 19.7 M | - | 16.6 M | 14.9 M | 11.3 M | - | 10.5 M | 11.2 M | 10.7 M | - | 9.35 M | 10.5 M | 9.99 M | - | 8.92 M | 10.6 M | 7.93 M | - | 7.75 M | 7.52 M | 7.97 M | - | 7.08 M | 6.86 M | 8.29 M | - | 7.54 M | 7.13 M | 7.52 M | - | 6.74 M | 6.59 M | 6.6 M | - | 6.92 M | 6.66 M | 6.72 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company eHealth (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Insurance brokers industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
BRP Group
BRP
|
- | -4.43 % | $ 1.81 B |  USA |
 |
GoHealth
GOCO
|
- | - | $ 4.01 M | USA |
 |
Marsh & McLennan Companies
MMC
|
- | - | $ 89.6 B | USA |
 |
Aon PLC
AON
|
$ 336.27 | 0.15 % | $ 72.6 B | USA |
 |
Fanhua
FANH
|
- | -0.65 % | $ 1.64 B |  China |
 |
Erie Indemnity Company
ERIE
|
$ 272.21 | 0.62 % | $ 14.2 B | USA |
 |
Arthur J. Gallagher & Co.
AJG
|
$ 283.14 | 0.91 % | $ 72.5 B | USA |
 |
Brown & Brown
BRO
|
$ 72.0 | 1.41 % | $ 22.3 B | USA |
 |
CorVel Corporation
CRVL
|
$ 83.75 | 1.84 % | $ 4.29 B | USA |
 |
Huize Holding Limited
HUIZ
|
$ 2.24 | -0.89 % | $ 2.26 B | China |
 |
SelectQuote
SLQT
|
$ 0.46 | 2.5 % | $ 86.6 M | USA |
 |
Willis Towers Watson Public Limited Company
WLTW
|
- | -0.49 % | $ 28.8 B |  Britain |